Publications by authors named "Marcella Mottolese"

100Publications

Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancer.

Crit Rev Oncol Hematol 2016 Oct 21;106:132-42. Epub 2016 Aug 21.

Scientific Direction, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.08.004DOI Listing
October 2016

Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.

Eur J Cancer 2016 May 7;58:52-61. Epub 2016 Mar 7.

Laboratory of Virology, Regina Elena National Cancer Institute, Rome, Italy; HPV-Unit, Regina Elena National Cancer Institute, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.02.001DOI Listing
May 2016

Androgen receptor and antiandrogen therapy in male breast cancer.

Cancer Lett 2015 Nov 11;368(1):20-25. Epub 2015 Aug 11.

Division of Medical Oncology B, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy; Scientific Direction, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.07.040DOI Listing
November 2015

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.

J Exp Clin Cancer Res 2015 Mar 21;34:26. Epub 2015 Mar 21.

Division of Medical Oncology B, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-015-0143-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393564PMC
March 2015

HER2 status determination: analyzing the problems to find the solutions.

Medicine (Baltimore) 2015 Apr;94(15):e645

From the Biostatistics, Scientific Direction, Regina Elena National Cancer Institute (IT); Pathology Department Catholic University of Sacred Heart (IP, VA); and Pathology Department Regina Elena National Cancer Institute-Rome, Italy (SB, MM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000000645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602505PMC
April 2015

ATM kinase sustains HER2 tumorigenicity in breast cancer.

Nat Commun 2015 Apr 16;6:6886. Epub 2015 Apr 16.

1] Laboratory of Cell Signaling, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, 00179 Rome, Italy [2] Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7886DOI Listing
April 2015

Triple positive breast cancer: a distinct subtype?

Cancer Treat Rev 2015 Feb 19;41(2):69-76. Epub 2014 Dec 19.

Oncology Unit, Sant'Andrea Hospital, "Sapienza" University of Rome, V Grottarossa 1035/1039, 00189 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.12.005DOI Listing
February 2015

Cancer stem cells: are they responsible for treatment failure?

Future Oncol 2014 Oct;10(13):2033-44

Division of Medical Oncology B, 'Regina Elena' National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.126DOI Listing
October 2014

Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.

Oncologist 2014 Nov 16;19(11):1118-26. Epub 2014 Oct 16.

Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy; Pathology Division, Santa Croce Hospital, Moncalieri, Italy; Pathology Division, Azienda USL Valle d'Aosta, Aosta, Italy; Pathology Division, Valdese Hospital, Turin, Italy; Pathology Division, Martini Hospital, Turin, Italy; Pathology Division, ASL 9, Civile Hospital, Ivrea, Italy; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy; Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221371PMC
November 2014

Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.

Breast Cancer Res Treat 2014 Nov 20;148(1):73-80. Epub 2014 Sep 20.

Division of Medical Oncology B, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3138-9DOI Listing
November 2014

Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic.

J Mol Med (Berl) 2014 Jul 28;92(7):681-95. Epub 2014 May 28.

Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-014-1169-7DOI Listing
July 2014

Cyclin D1 is a major target of miR-206 in cell differentiation and transformation.

Cell Cycle 2013 Dec 8;12(24):3781-90. Epub 2013 Oct 8.

Dipartimento di Biologia e Biotecnologie "C. Darwin"; Sapienza-Università di Roma; Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.26674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905070PMC
December 2013

Minimum biobanking requirements: issues in a comprehensive cancer center biobank.

Biopreserv Biobank 2011 Jun;9(2):141-8

1 Giovanni Paolo II National Cancer Center , Bari, Italy .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2011.0012DOI Listing
June 2011

Gene copy number variation in male breast cancer by aCGH.

Cell Oncol (Dordr) 2011 Oct 6;34(5):467-73. Epub 2011 May 6.

Clinical Experimental Oncology Laboratory, National Cancer Centre of Bari, viale Orazio Flacco 65, 70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-011-0041-9DOI Listing
October 2011

Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.

J Exp Clin Cancer Res 2008 Sep 19;27:39. Epub 2008 Sep 19.

Gastroenterology and Digestive Endoscopic Unit, Regina Elena Cancer Institute Via Elio Chianesi 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-27-39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559820PMC
September 2008

HER-2-positive metastatic breast cancer: trastuzumab and beyond.

Expert Opin Pharmacother 2008 Oct;9(15):2583-601

Regina Elena Cancer Institute, Division of Medical Oncology A, Via Elio Chianesi, 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.9.15.2583DOI Listing
October 2008